The comparison of EGFR-TKI failure modes and subsequent management between exon 19 deletion and exon 21 L858R mutation in advanced non-small-cell lung cancer

Background: Advanced non-small-cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion (19 Del) and exon 21 L858R mutation (L858R) might be distinct diseases. Therefore, it is necessary to take EGFR mutation subgroups into consideration for making choices of subsequent...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Cancer
Päätekijät: Zhang, Yaxiong, Chen, Gang, Chen, Xi, Fang, Wenfeng, Gao, Fei, Yang, Yunpeng, Zhao, Yuanyuan, Ma, Yuxiang, Hong, Shaodong, Zhang, Zhonghan, Miao, Siyu, Wu, Manli, Huang, Xiaodan, Luo, Youli, Zhou, Cong, Gong, Run, Huang, Yan, Chen, Likun, Zhou, Ningning, Zhao, Hongyun, Zhang, Li
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ivyspring International Publisher 2017
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5556650/
https://ncbi.nlm.nih.gov/pubmed/28819384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.19867
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia